This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Don Riesenberg, MD

JAMA. 1988;260(20):3054.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The use and misuse of medications in elderly persons who reside in long-term—care institutions have important consequences. Psychotropic drugs are among those that greatly affect the quality of life for the roughly 1.5 million institutionalized elderly persons in the United States. It is well known that some benzodiazepines, eg, diazepam, boast a much longer half-life in elderly patients.¹ Such antipsychotics as thioridazine, may cause significant orthostatic hypotension,² as is the case with certain tricyclic antidepressants. Additionally, the latter class of drugs includes some that produce anticholinergic side effects,³ which can result in urinary retention for patients with tenuous bladder function, such as men with prostatic hypertrophy. The study by Beers et al,⁴ in this issue of THE JOURNAL, inspires little confidence in prescribing practices in the long-term—care setting, specifically intermediate-care facilities (ICFs). Twelve such institutions in eastern Massachusetts, shown to be representative of those in the . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?